The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children

From BugSigDB
Reviewed Marked as Reviewed by KateRasheed on 2025-6-13
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
Authors
Wu Z, Jiang M, Jia M, Sang J, Wang Q, Xu Y, Qi L, Yang W, Feng L
Journal
Communications biology
Year
2025
Acute respiratory infections (ARI) with multiple types of viruses are common in infants and children. This study was conducted to assess the difference of oropharyngeal microbiome during acute respiratory viral infection using whole-genome shotgun metagenomic sequencing. The overall taxonomic alpha diversity did not differ by the types of infected virus. The beta diversity differed by disease severity, disease-related symptoms, and types of infected virus. Nine species had significantly higher abundance in outpatients than in inpatients, with five of them in the genus Achromobacter. Three microbial community types were identified. The prevalence of community type (CT) 1 was higher among patients with influenza virus, enterovirus, and human adenvirus; CT2 was higher among patients with human metapneumovirus; and CT3 was higher among patients with respiratory syncytial virus and human adenvirus infections. Our results suggest that the oropharyngeal microbiome is associated with ARI disease severity, disease-related symptoms, and the types of infected virus.

Experiment 1


Reviewed Marked as Reviewed by KateRasheed on 2025-6-13

Curated date: 2025/05/04

Curator: Shulamite

Revision editor(s): Shulamite, Anne-mariesharp

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Oropharynx Mesopharynx,Oral part of pharynx,Pars oralis pharyngis,Oropharynx,oropharynx
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Respiratory tract infectious disease infection, respiratory tract,infections, respiratory,infections, respiratory tract,infections, upper respiratory,infections, upper respiratory tract,respiratory infection, upper,respiratory infections,respiratory tract infection,upper respiratory infections,upper respiratory tract infections,Respiratory tract infectious disease,respiratory tract infectious disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Inpatients
Group 1 name Corresponds to the case (exposed) group for case-control studies
Outpatients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Children with Acute respiratory infections (ARI) who visited the hospital but did not require hospitalization.
Group 0 sample size Number of subjects in the control (unexposed) group
49
Group 1 sample size Number of subjects in the case (exposed) group
60

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-6-13

Curated date: 2025/05/04

Curator: Shulamite

Revision editor(s): Shulamite

Source: Fig. 2F and G

Description: LDA score and relative abundance of 15 significantly different taxa calculated by LEfSe analysis.

Abundance in Group 1: increased abundance in Outpatients

NCBI Quality ControlLinks
Brucellaceae
Brucella
Brucella anthropi
Alcaligenaceae
Achromobacter
Burkholderiales
Achromobacter aegrifaciens
Achromobacter marplatensis
Achromobacter xylosoxidans
Pseudomonas putida
Enterobacteriaceae
Enterobacter
Enterobacterales
Enterobacter kobei
Achromobacter pestifer

Revision editor(s): Shulamite

Experiment 2


Reviewed Marked as Reviewed by KateRasheed on 2025-6-13

Curated date: 2025/05/04

Curator: Shulamite

Revision editor(s): Shulamite, Anne-mariesharp

Differences from previous experiment shown

Subjects

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Children with ARI who visited the hospital but did not require hospitalization.

Lab analysis

Statistical Analysis

Statistical test
Mann-Whitney (Wilcoxon)
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
Not specified

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-6-13

Curated date: 2025/05/04

Curator: Shulamite

Revision editor(s): Shulamite

Source: Table S3

Description: Two-fold changes of microbial abundances between inpatients and outpatients.

Abundance in Group 1: increased abundance in Outpatients

NCBI Quality ControlLinks
Enterobacter kobei
Achromobacter marplatensis
Pseudomonas putida
Brucella anthropi
Achromobacter aegrifaciens
Achromobacter xylosoxidans
Achromobacter insolitus
Achromobacter pestifer
Ochrobactrum sp. CGA5

Revision editor(s): Shulamite

Experiment 3


Reviewed Marked as Reviewed by KateRasheed on 2025-6-13

Curated date: 2025/05/04

Curator: Shulamite

Revision editor(s): Shulamite, Anne-mariesharp, KateRasheed

Differences from previous experiment shown

Subjects

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Fatigue Fatigue,Tired,Tiredness,fatigue
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Non-fatigue
Group 1 name Corresponds to the case (exposed) group for case-control studies
Fatigue
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Children who exhibited fatigue as part of their clinical presentation of ARI.
Group 0 sample size Number of subjects in the control (unexposed) group
Not specified
Group 1 sample size Number of subjects in the case (exposed) group
Not specified

Lab analysis

Statistical Analysis

Statistical test
LEfSe
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-6-13

Curated date: 2025/05/04

Curator: Shulamite

Revision editor(s): Shulamite, Anne-mariesharp

Source: Table S4

Description: Differences of taxonomic relative abundance between disease-related symptom groups by LEfSe analysis.

Abundance in Group 1: increased abundance in Fatigue

NCBI Quality ControlLinks
Moraxella catarrhalis
Porphyromonas catoniae
GGB12794GGB12794
GGB12794_SGB19881GGB12794_SGB19881
Lactococcus
Lactococcus lactis

Revision editor(s): Shulamite, Anne-mariesharp